Literature DB >> 2068555

Mortality of employees in plants manufacturing 4,4'-bipyridyl.

G M Paddle1, A J Osborn, G D Parker.   

Abstract

A historical-prospective cohort study was conducted of 729 male employees of plants manufacturing 4,4'-bipyridyl. The cohort was studied because employment in some of the plants had been linked to malignant and nonmalignant skin lesions attributed to exposure to tarry by-products. The overall mortality experience of the cohort did not show any statistically significant findings. More-detailed analysis of subdivision of the cohort gave results that justified further inquiry into lung cancer incidence. A nested case-referent study did not indicate that any occupational factor other than employment in a bipyridyl plant was related to the incidence of lung cancer. The epidemiologic, toxicologic, and industrial hygiene information was assessed, and it was concluded that there was no evidence of a plausible occupational hazard of lung cancer to the bipyridyl workers, but that a follow-up of the cohort after an interval of five years should be undertaken.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068555     DOI: 10.5271/sjweh.1714

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  3 in total

1.  Survey of methods and statistical models used in the analysis of occupational cohort studies.

Authors:  P W Callas; H Pastides; D W Hosmer
Journal:  Occup Environ Med       Date:  1994-10       Impact factor: 4.402

2.  Mortality from Parkinson's disease and other causes among a workforce manufacturing paraquat: a retrospective cohort study.

Authors:  John Andrew Tomenson; Clive Campbell
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

3.  Mortality from Parkinson's disease and other causes among a workforce manufacturing paraquat: an updated retrospective cohort study.

Authors:  John Andrew Tomenson; Clive Campbell
Journal:  J Occup Med Toxicol       Date:  2021-05-27       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.